Vulvar and vaginal squamous cell carcinoma · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Track | standard |
|---|---|
| Linked regimen | None |
| ID | IND-IATROGENIC-DES-EXPOSURE-PREVENTION-SURVEILLANCE |
|---|---|
| Type | Indication |
| Status | reviewed 2026-05-18 | pending_clinical_signoff |
| Diseases | DIS-VULVAR-VAGINAL-SCC |
| Sources | SRC-IARC-MONO-100B-2012 SRC-NCCN-CERVICAL-2025 |
Notes
STUB — v0.3 iatrogenic pilot (in-utero DES exposure → vaginal CCA + cervical CIS). Two-Clinical-Co-Lead signoff queued. Critical: cervical Pap is NOT sufficient; full vaginal-wall inspection by DES-experienced gynecologist is the standard. Anchored to DIS-VULVAR-VAGINAL-SCC (anatomic site) — clear-cell adenocarcinoma histology specificity carried in prose; future DIS-VAGINAL-CLEAR-CELL entity recommended.
Used By
No reverse references found in the YAML corpus.